# TT52CAR19 Therapy for B-cell Acute Lymphoblastic Leukaemia (B-ALL)

> **NCT04557436** · PHASE1 · COMPLETED · sponsor: **Great Ormond Street Hospital for Children NHS Foundation Trust** · enrollment: 9 (actual)

## Conditions studied

- B Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** PBLTT52CAR19

## Key facts

- **NCT ID:** NCT04557436
- **Lead sponsor:** Great Ormond Street Hospital for Children NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-12
- **Primary completion:** 2024-03-05
- **Final completion:** 2024-03-05
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2024-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04557436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04557436, "TT52CAR19 Therapy for B-cell Acute Lymphoblastic Leukaemia (B-ALL)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04557436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*